文献速递消化系统肿瘤

雌激素受体β与女性结直肠癌患者激素状态及预后的关联

Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer.
PubMed 文献 · Eur J Cancer · 2017-07-29

该研究对320例女性结直肠癌患者的原发肿瘤组织芯片进行ERβ免疫组化染色,评估ERβ表达与总生存、无病生存、激素状态及生活方式的关系。314例成功检测者中182例(58%)低表达、132例(42%)高表达;多因素Cox分析显示高表达者总死亡风险降低50%(HR 0.50,95%CI 0.30-0.83)、癌症复发风险降低76%(HR 0.24,95%CI 0.11-0.52)。高表达与较短母乳喂养时间及较长激素替代治疗使用显著相关,与生活方式指标无关。

要点

  • 314例女性结直肠癌中ERβ低表达182例(58%)、高表达132例(42%)。
  • 高ERβ表达者总死亡风险HR 0.50(95%CI 0.30-0.83),复发风险HR 0.24(95%CI 0.11-0.52)。
  • 高ERβ表达与较短母乳喂养时间、较长激素替代治疗使用显著相关,与生活方式无关。

核心结论

  • 在女性结直肠癌患者中,ERβ高表达与更好的预后及激素状态独立相关,但与生活方式指标无关。

研究设计与样本

  • 对320例女性结直肠癌患者的原发肿瘤组织芯片进行单克隆抗ERβ抗体免疫组化染色,评估染色强度。
  • 分析ERβ表达与总生存、无病生存、激素状态及生活方式的关联,并报告效应估计值及95%置信区间。

主要发现

  • 314例成功检测ERβ的样本中,182例(58%)低表达,132例(42%)高表达。
  • 校正年龄、TNM分期和肿瘤血管侵犯后,高ERβ表达者总死亡风险降低50%(HR 0.50,95%CI 0.30-0.83),癌症复发风险降低76%(HR 0.24,95%CI 0.11-0.52)。
  • 高ERβ表达与较短母乳喂养时间及较长激素替代治疗使用显著相关。
  • ERβ表达与生活方式指标之间未发现关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The oestrogen receptor beta (ERβ) is the predominant oestrogen receptor in the normal colon mucosa and has been reported to exert anti-proliferative and pro-apoptotic effects. However, the role of ERβ in colorectal cancer (CRC) progression remains unclear. AIM: To investigate the role of ERβ and its association with hormone status and lifestyle indicators in a female cohort of patients with CRC. METHODS: Tissue microarrays of primary CRC tumour samples from 320 female patients were conducted with a monoclonal anti-ERβ antibody. The staining intensity was evaluated using immunohistochemistry. The association of ERβ expression with overall survival, disease-free survival, hormone status and lifestyle was evaluated, and effect estimators with 95% confidence intervals (CIs) were reported. RESULTS: Among the 314 samples with successfully detected ERβ, 182 (58%) had low expression and 132 (42%) had high expression. The Cox multivariate analysis indicated that patients with high ERβ expression had a decreased risk of overall mortality by 50% (hazard ratio [HR], 0.50; CI, 0.30-0.83) and of cancer recurrence by 76% (HR, 0.24; CI, 0.11-0.52) after adjusting for age, tumour-node-metastasis stage and tumour intravascular invasion. Furthermore, high ERβ expression was significantly correlated with shorter breastfeeding time and longer use of hormone replacement therapy. No association was found between ERβ expression and lifestyle indicators. CONCLUSION: Elevated ERβ expression is independently associated with a better prognosis and hormone status but not lifestyle indicators in female CRC patients.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Topi G, Ehrnström R, Jirström K, et al. Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer. Eur J Cancer. 2017. PMID: 28763692. doi:10.1016/j.ejca.2017.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。